APA

Thaçi D., Papp K., Marcoux D., Weibel L., Pinter A., Ghislain P., Landells I., Hoeger P. H., Unnebrink K., Seyger M. M. B., Williams D. A., Rubant S. & Philipp S. (20210315). Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study. : The British journal of dermatology.

Chicago

Thaçi D, Papp K, Marcoux D, Weibel L, Pinter A, Ghislain P-D, Landells I, Hoeger P H, Unnebrink K, Seyger M M B, Williams D A, Rubant S and Philipp S. 20210315. Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study. : The British journal of dermatology.

Harvard

Thaçi D., Papp K., Marcoux D., Weibel L., Pinter A., Ghislain P., Landells I., Hoeger P. H., Unnebrink K., Seyger M. M. B., Williams D. A., Rubant S. and Philipp S. (20210315). Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study. : The British journal of dermatology.

MLA

Thaçi D, Papp K, Marcoux D, Weibel L, Pinter A, Ghislain P-D, Landells I, Hoeger P H, Unnebrink K, Seyger M M B, Williams D A, Rubant S and Philipp S. Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study. : The British journal of dermatology. 20210315.